STRNY
Severn Trent Plc$39.72
LiveJun 12, 2026
Market cap
$11.98B
52w range
33.73 – 45.46
P / E
—
EPS · FY 2026
$1.25
Volume
1.1K
Revenue · FY 2026
$2.88B
Explain this page
Arphra AIPlain-English read on Severn Trent Plc’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
BSolid
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin32.0%
Operating margin30.4%
Net margin13.1%
ROE20.5%
ROA2.1%
ROIC4.8%
Liquidity & leverage
Current ratio1.39×
Quick ratio1.35×
Debt / equity5.97×
Net debt / EBITDA7.93×
Interest coverage2×
Efficiency & per-share
Asset turnover0.16×
Inventory days9
Days sales out.118
FCF / share$-3.28
Book value / share$6.11
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Headline | |||||
| Market cap | $9.45B | — | — | — | — |
| Enterprise value | $20.41B | — | — | — | — |
| Multiples | |||||
| P / E | — | — | — | — | — |
| P / B | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / Sales | 7.09 | — | — | — | — |
| EV / FCF | -20.66 | — | — | — | — |
| Yields | |||||
| Earnings yield | +3.99% | — | — | — | — |
| Free cash flow yield | -10.45% | — | — | — | — |
| Dividend yield | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Margins | |||||
| Gross margin | +32.04% | +32.45% | +31.42% | +32.00% | +32.21% |
| Operating margin | +30.41% | +30.29% | +30.50% | +30.37% | +31.09% |
| EBITDA margin | +48.00% | +46.92% | +47.38% | +49.26% | +47.95% |
| EBIT margin | +30.41% | +31.21% | +30.99% | +29.88% | +29.91% |
| Pre-tax margin | +18.51% | +18.20% | +18.24% | +18.87% | +18.20% |
| Net margin | +13.10% | +13.35% | +12.87% | +13.24% | +12.98% |
| Cost structure | |||||
| Cost of revenue / sales | +67.96% | +67.12% | +67.79% | +69.12% | +66.31% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +1.62% | +1.61% | +1.67% | +1.65% | +1.65% |
| Effective tax rate | +29.20% | +29.05% | +29.75% | +29.17% | +30.23% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity (ROE) | +20.48% | +20.44% | +20.30% | +20.46% | +20.54% |
| Return on assets (ROA) | +2.15% | +2.19% | +2.12% | +2.19% | +2.18% |
| Return on capital (ROC) | +6.82% | +6.76% | +6.87% | +6.76% | +6.84% |
| Return on invested capital (ROIC) | +2.94% | +2.98% | +2.90% | +2.95% | +2.86% |
| Asset turnover | +16.37% | +16.40% | +16.51% | +16.55% | +16.78% |
| DuPont · ROE decomposition | |||||
| Net margin | +13.10% | +13.35% | +12.87% | +13.24% | +12.98% |
| Asset turnover (× revenue / assets) | +16.37% | +16.40% | +16.51% | +16.55% | +16.78% |
| Equity multiplier (× assets / equity) | +954.43% | +933.61% | +955.68% | +933.53% | +942.99% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Turnover | |||||
| Asset turnover | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 |
| Fixed-asset turnover | 0.19 | — | — | — | — |
| Inventory turnover | 40.73 | — | — | — | — |
| Receivables turnover | 3.08 | — | — | — | — |
| Payables turnover | 2.24 | — | — | — | — |
| Days outstanding | |||||
| Days sales outstanding (DSO) | 118.37 | — | — | — | — |
| Days inventory outstanding (DIO) | 8.96 | — | — | — | — |
| Days payables outstanding (DPO) | 162.79 | — | — | — | — |
| Cash conversion cycle | -35.45 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Operating CF / Net income | 2.49 | 2.48 | 2.50 | 2.42 | 2.47 |
| FCF / Net income | -2.62 | -2.58 | -2.65 | -2.54 | -2.62 |
| FCF margin | -34.33% | -34.39% | -34.13% | -33.65% | -34.05% |
| OCF margin | +32.64% | +33.07% | +32.21% | +32.02% | +32.08% |
| CapEx / Revenue | +66.97% | +65.29% | +67.78% | +68.92% | +66.50% |
| CapEx / D&A | 3.81 | — | — | — | — |
| Stock-based comp / Revenue | 0.00% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| EPS · diluted | 1.25 | 2.08 | 2.50 | 2.69 | 2.78 |
| EPS · basic | 1.26 | 2.07 | 2.54 | 2.72 | 2.76 |
| Book value / share | 6.11 | 6.84 | 7.34 | 7.90 | 8.34 |
| Tangible BV / share | 4.86 | 6.84 | 7.34 | 7.90 | 8.34 |
| Sales / share | 9.54 | 10.47 | 11.57 | 12.21 | 13.20 |
| Operating CF / share | 3.11 | 3.46 | 3.73 | 3.91 | 4.24 |
| Free cash flow / share | -3.28 | -3.60 | -3.95 | -4.11 | -4.50 |
| Dividends / share | 1.25 | 1.40 | 1.50 | 1.57 | 1.69 |
| Payout ratio | +100.00% | +100.18% | +100.93% | +97.12% | +98.64% |
| Retention ratio | 0.00% | -0.18% | -0.93% | +2.88% | +1.36% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E | 4y CAGR |
|---|---|---|---|---|---|---|
| Top-line | ||||||
| Revenue · YoY | — | +10.39% | +10.15% | +5.87% | +7.15% | +8.38% |
| Gross profit · YoY | — | +11.82% | +6.65% | +7.83% | +7.84% | +8.52% |
| Profit | ||||||
| Operating income · YoY | — | +9.94% | +10.93% | +5.42% | +9.68% | +8.97% |
| EBITDA · YoY | — | +7.90% | +11.25% | +10.06% | +4.31% | +8.35% |
| Net income · YoY | — | +12.45% | +6.20% | +8.96% | +5.02% | +8.12% |
| Operating | ||||||
| EBIT · YoY | — | +13.28% | +9.38% | +2.08% | +7.26% | +7.92% |
| R&D · YoY | — | — | — | — | — | — |
| Per-share | ||||||
| EPS · diluted · YoY | — | +66.56% | +20.13% | +7.69% | +3.26% | +22.13% |
| EPS · basic · YoY | — | +64.60% | +22.33% | +7.31% | +1.45% | +21.68% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Leverage | |||||
| Total debt | $10.98B | $12.15B | $13.31B | $14.23B | $15.54B |
| Net debt | $10.95B | $12.11B | $13.27B | $14.19B | $15.49B |
| Net debt / EBITDA | 7.93 | 8.13 | 8.00 | 7.78 | 8.14 |
| Debt / equity | 5.97 | 5.86 | 6.00 | 5.94 | 6.19 |
| Debt / assets | +62.51% | +62.75% | +62.79% | +63.60% | +65.68% |
| Equity / assets | +10.48% | +10.71% | +10.46% | +10.71% | +10.60% |
| Coverage | |||||
| EBITDA / interest expense | 3.86 | 3.69 | 3.75 | 4.06 | 3.75 |
| Operating income / interest | 2.45 | 2.39 | 2.42 | 2.51 | 2.43 |
| Interest expense | $357.72M | $403.32M | $441.58M | $448.88M | $507.93M |
| Liquidity | |||||
| Current ratio | 1.39 | — | — | — | — |
| Quick ratio | 1.34 | — | — | — | — |
| Cash ratio | 0.03 | — | — | — | — |
| Working capital | $504.02M | — | — | — | — |
| Working capital / revenue | +17.52% | — | — | — | — |
Historical multiples · μ ± σ bands
3 fiscal-year-end observations from key_metrics. Mean is dashed; light-green band is ±1σ, light-red band ±2σ. The dot marks the most recent value; the cheap / fair / rich verdict uses z-score against the issuer's own history (yields inverted — a high yield is cheap).
EV / Salesrich · z 1.09
μ 6.6 · σ 0.4 · current 7.1
EV / FCFfair · z 0.90
μ -28.2 · σ 8.4 · current -20.7
Earnings yieldcheap · z 1.23
μ 3.0% · σ 0.8% · current 4.0%
FCF yieldrich · z -1.03
μ -8.2% · σ 2.2% · current -10.4%
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| P / E | — | — | — |
| P / B | — | — | — |
| EV / EBITDA | — | — | — |
| EV / Sales | 7.09x | 6.74x | 6.09x |
| Earnings yield | 4.0% | 3.0% | 2.0% |
| FCF yield | -10.4% | -8.9% | -5.2% |
Returns
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| ROE | 20.5% | 13.0% | 7.6% |
| ROA | 2.1% | 1.4% | 1.0% |
| ROIC | 3.7% | 2.9% | 2.5% |
Leverage & liquidity
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / equity | — | — | — |
| Net debt / EBITDA | 7.93 | 7.50 | 8.25 |
| Interest coverage | — | — | — |
| Current ratio | 1.39x | 1.37x | 2.14x |
| Quick ratio | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).